LivingGLP1
Study S001804

Standard of Care or Weight Loss Drug Therapy in Obesity-related Hypertension - Pilot Study

Registration

Registration
NCT07364175
Acronym
SOLUTION-Pilot
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Status
RECRUITING
Enrollment
60
Start
2026-01
Primary completion
2027-01
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust
Conditions
Hypertension; Obesity & Overweight
Interventions
DRUG:Tirzepatide; DRUG:Anti-Hypertensive medications
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Ambulatory systolic blood pressure [Baseline to week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.